Evidence map›Paper›PMID 37888600›Full record

ArticleTropical medicine and infectious disease2023

Clinical and Laboratory Response of Domiciled Dogs with Visceral Leishmaniasis Treated with Miltefosine and Allopurinol.

Talita Pereira Vaz, Patrícia Flávia Quaresma, Felipe Dutra Rêgo, Camila Binder Souza, Gilberto Fontes, Célia Maria Ferreira Gontijo

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Visceral Leishmaniasis in Southern Brazil: an overview of current epidemiology.Revista da Sociedade Brasileira de Medicina Tropical · 2026
    Review
  3. Review
  4. Oleylphosphocholine versus Miltefosine for Canine Leishmaniasis.The American journal of tropical medicine and hygiene · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Talita Pereira VazRené Rachou Institute (FIOCRUZ/MG), Av. Augusto de Lima, 1715, Barro Preto, Belo Horizonte 30190-009, MG, Brazil.
Patrícia Flávia QuaresmaCampus Reitor João Davi Ferreira Lima, Federal University of Santa Catarina, Trindade, Florianópolis 88040-900, SC, Brazil.ORCID 0000-0001-8274-4166
Felipe Dutra RêgoRené Rachou Institute (FIOCRUZ/MG), Av. Augusto de Lima, 1715, Barro Preto, Belo Horizonte 30190-009, MG, Brazil.ORCID 0000-0002-2799-8267
Camila Binder SouzaRené Rachou Institute (FIOCRUZ/MG), Av. Augusto de Lima, 1715, Barro Preto, Belo Horizonte 30190-009, MG, Brazil.
Gilberto FontesCampus Centro Oeste, Federal University of São João del Rei (UFSJ), Sebastião Gonçalves Coelho, 400, Divinópolis 35501-296, MG, Brazil.ORCID 0000-0003-3930-547X
Célia Maria Ferreira GontijoRené Rachou Institute (FIOCRUZ/MG), Av. Augusto de Lima, 1715, Barro Preto, Belo Horizonte 30190-009, MG, Brazil.ORCID 0000-0002-7034-535X
Fundação Oswaldo Cruz · BRFederal University of São João del-Rei · BRUniversidade Federal de Santa Catarina · BR

Funding

Oswaldo Cruz Foundation INOVA Nº 761464687
6 · The paper itself

Abstract

Canine visceral leishmaniasis (CVL) remains a significant disease worldwide. In Brazil, its treatment is performed using miltefosine, which has demonstrated promising outcomes in dogs. This study represents the first attempt to treat and monitor dogs with CVL in natural conditions over the course of one year. The dogs were divided into two groups: G1 received miltefosine and allopurinol for 28 days, while G2 received miltefosine for 28 days, followed by allopurinol for one year. The follow-up involved clinical, hematological, and biochemical evaluations, as well as the detection of

Indexed as

dogLeishmania infantumtreatment

Identifiers

PMID37888600
PMCPMC10610677
OpenAlexW4387494039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.